Form 8-K - Current report:
SEC Accession No. 0000950170-25-011197
Filing Date
2025-01-30
Accepted
2025-01-30 17:19:05
Documents
12
Period of Report
2025-01-28
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K revb-20250128.htm   iXBRL 8-K 56434
2 EX-3.1 revb-ex3_1.htm EX-3.1 14506
  Complete submission text file 0000950170-25-011197.txt   230956

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT revb-20250128.xsd EX-101.SCH 49143
14 EXTRACTED XBRL INSTANCE DOCUMENT revb-20250128_htm.xml XML 6950
Mailing Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122
Business Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122 650-800-3717
REVELATION BIOSCIENCES, INC. (Filer) CIK: 0001810560 (see all company filings)

EIN.: 843898466 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39603 | Film No.: 25574922
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)